Craig Best, D.O., a pain management specialist, has joined Midwest Orthopaedics at Rush. Dr. Best is a board-certified physical medicine and rehabilitation/interventional pain medicine specialist who brings comprehensive non-surgical spine expertise to improving patients’ lives.
Craig Best, D.O Joins Midwest Orthopaedics at Rush

After earning a medical degree at Lincoln Memorial University DeBusk College of Osteopathic Medicine, Dr. Best’s physical medicine & rehabilitation (physiatry) residency training was at Rush University Medical Center. That was followed by fellowship training in interventional pain medicine at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital.
“Dr. Best’s goal for his patients is to improve their pain and function, allowing for a more active and fulfilling lifestyle,” said Midwest Orthopaedics at Rush. “He identifies patients’ specific pain generators by utilizing a thorough history and physical examination, imaging, electrodiagnostic studies, and diagnostic injections. He then prescribes an individualized treatment plan that may consist of medications, detailed physical/occupational therapy or exercise prescriptions, and/or a wide variety of injections and minimally invasive procedures.”
A researcher, Dr. Best has published articles on spine and musculoskeletal medicine. In addition, he has lectured in the Greater Chicago Area, including at Rush University Medical Center. He is a member of the Spine Intervention Society and North American Spine Society.
Dr. Best commented to OTW, “My hope is that I’m able to continue to provide excellent non-surgical spine/pain care while also expanding the interventional orthobiologics and regenerative medicine program to include more spine care.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.